Treatment of therapy-related acute myeloid leukemia occurring in elderly non-Hodgkin lymphoma patients with low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor

Leuk Res. 2009 Jan;33(1):197-200. doi: 10.1016/j.leukres.2008.04.002. Epub 2008 May 12.

Authors

Hiro Tatetsu, Fumihiko Matsuno, Noritaka Takatsu, Hirosada Miyake, Koyu Hoshino, Kisato Nosaka, Kentaro Horikawa, Hiroyuki Hata, Hiroaki Mitsuya, Norio Asou

PMID: 18472159
DOI: 10.1016/j.leukres.2008.04.002

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aclarubicin / administration & dosage
Aged
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Cytarabine / administration & dosage
Female
Granulocyte Colony-Stimulating Factor / administration & dosage
Humans
Leukemia, Myeloid, Acute / chemically induced*
Lymphoma, Non-Hodgkin / complications*
Lymphoma, Non-Hodgkin / drug therapy*
Male
Neoplasms, Second Primary / chemically induced*

Substances

Cytarabine
Granulocyte Colony-Stimulating Factor
Aclarubicin